Monkeypox Outbreak May Boost the Shares of These Companies
- Vaccine maker Bavarian more than tripled from a low in May
- Virus detection, medical equipment makers are also on radar
This article is for subscribers only.
As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease.
Shares of vaccine producers, antiviral drug makers and protective equipment manufacturers are in demand as investors tap a strategy that delivered gains during the coronavirus pandemic. Biotechnological company Bavarian Nordic A/S and pharmaceutical firm Siga Technologies Inc. are among the stocks in focus as well as medical tools supplier Precision System Science Co.